novo glp 1 drugs Novo's Wegovy becomes first GLP-1 drug approved for MASH US FDA accepts Novo Nordisk's

Reduce the GLP-1 dose over several weeks while simultaneously starting the alternative medication

Very recently, GLP1 monotherapies have also been applied in the pharmacological management of PCOS, with promising results 32 , which are yet to be consolidated in clinical practice

Tirzepatide titration: 2.5mg to 15mg Tirzepatide uses a six-step titration over approximately 20-24 weeks: Weeks 1-4: 2.5mg weekly Weeks 5-8: 5mg weekly Weeks 9-12: 7.5mg weekly Weeks 13-16: 10mg weekly Weeks 17-20: 12.5mg weekly Week 21 onward: 15mg weekly (maximum dose) Not everyone reaches 15mg

GLP-1 agonists have been used as a treatment for type 2 diabetes for nearly two decades

Research on GLP-1 therapy discontinuation suggests that certain metabolic improvements show partial persistence even after weight regain

19 December 2024: FDA confirms tirzepatide shortage is still over, gives compounders a grace period Eli Lilly strikes Zepbound deal with Ro, amid questions about future of compounded GLP-1s